RHUMBLINE ADVISERS - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$1,786,000
+115.7%
52,829
+49.3%
0.00%
+100.0%
Q1 2021$828,000
-25.4%
35,394
-8.2%
0.00%
-50.0%
Q4 2020$1,110,000
+51.8%
38,550
+6.8%
0.00%
+100.0%
Q3 2020$731,000
-39.7%
36,096
-10.5%
0.00%
-50.0%
Q2 2020$1,212,000
+60.7%
40,331
+68.2%
0.00%0.0%
Q1 2020$754,000
-21.3%
23,974
+17.9%
0.00%0.0%
Q4 2019$958,000
+648.4%
20,331
+2.4%
0.00%
Q3 2019$128,000
-47.3%
19,860
+0.2%
0.00%
Q2 2019$243,000
+10.0%
19,824
+21.5%
0.00%
Q1 2019$221,00016,3120.00%
Other shareholders

There were no reported owners of CONSTELLATION PHARMCETICLS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CONSTELLATION PHARMCETICLS I shareholders